Save the date
2022 CeZAP Infectious Diseases Symposium
October 7, 2022
8:30 am - 5:30 pm
The Inn at Virginia Tech
Keynote speakers include:
Jennifer McQuiston
Deputy Director, Division of High Consequence Pathogens and Pathology
Centers for Disease Control and Prevention
T. Jake Liang
NIH Distinguished Investigator and Member of National Academy of Medicine, NIH
Sue VandeWoude
Director of One Health Institute and Member of National Academy of Sciences, Colorado State University
|
|
|
ID IGEP affiliated students Marcel Shams Eddin, Carolina Martinez, Matt Flores, Jason Pough, Abdullahi Jamiu and Jaspreet Gill having fun at the CeZAP Spring Mix & Mingle Selfie Station
|
|
Congratulations to Rebecca Hester on receiving the College of Liberal Arts and Human Sciences Diversity Award
|
|
Hester’s nomination described her work as “programmatic and expansive; she is a true agent of change in curricula and pedagogy centered on important issues, and on outreach to newcomer communities. Hester’s support of diversity reflects a deep commitment and is thoroughly integrated across teaching, service, and research. She thus serves as an excellent model of what diversity work can be at the university.” READ MORE>>
|
|
|
Recent Publications by CeZAP Affiliated Faculty
|
|
Giraffe skin disease: Clinicopathologic characterization of cutaneous filariasis in the critically endangered Nubian giraffe ( Giraffa camelopardalis camelopardalis)
Han S, Dadone L, Ferguson S, Bapodra-Villaverde P, Dennis PM, Aruho R, Sadar MJ, Fennessy J, Driciru M, Muneza AB, Brown MB, Johnston M, Lahmers K. Vet Pathol
DOI: 10.1177/03009858221082606
Investigating plant disease outbreaks with long-read metagenomics: sensitive detection and highly resolved phylogenetic reconstruction applied to Xylella fastidiosa Johnson M, Liu H, Bush E, Sharma P, Yang S, Mazloom R, Heath L, Nita M, Li S, Vinatzer B. Microb Genom DOI: 10.1099/mgen.0.000822
Could a Focus on the "Why" of Taxonomy Help Taxonomy Better Respond to the Needs of Science and Society? Pritchard L, Brown C. Harrington B, Heath L, Pierce-Ward, Vinatzer B. Front Microbiol
DOI: 10.3389/fmicb.2022.887310
African Animal Trypanosomiasis: A Systematic Review on Prevalence, Risk Factors, and Drug Resistance in Sub-Saharan Africa Okello I, Mafie E, Eastwood G, Nzalawahe J, Mboera LG J Med Entomol DOI: 10.1093/jme/tjac018
Biophysical insights into OR2T7: Investigation of a potential prognostic marker for glioblastoma Sharp A, Newman D, Libonate G, Borns-Stern M, Bevan D, Brown AM, Anandakrishnan R. Biophys J.
DOI: 10.1016/j.bpj.2022.05.009
Rehabilitation of misbehaving microbiome: phages for the remodeling of bacterial composition and function. Baaziz H, Baker Z, Franklin H Hsu B. iScience DOI: 10.1016/j.isci.2022.104146
|
Behavioral and postural analyses establish sleep-like states for mosquitoes that can impact host landing and blood feeding Ajayi O, Marlman J, Gleitz L, Smith E, Piller B, Krupa J, Vinauger C, Benoit J. J Exp Biol DOI: 10.1242/jeb244032
Mechanistic Studies in In Vivo Efficacy of an Oxadiazole-Containing Antibiotic Naclerio GA, Abutaleb NS, Onyedibe KI, Karanja C, Eldesouky HE, Liang HW, Dieterly A, Aryal UK, Lyle T, Seleem MN, Sintim HO. J Med Chem DOI: 10.1021/acs.jmedchem.1c02034
Trypanosoma cruzi strain and starvation-driven mitochondrial RNA editing and transcriptome variability Gerasimov ES, Ramirez-Barrios R, Yurchenko V, Zimmer SL. RNA DOI: 10.1261/rna.079088.121
The Consistent Tick-Vertebrate Infectious Cycle of the Lyme Disease Spirochete Enables Borrelia burgdorferi To Control Protein Expression by Monitoring Its Physiological Status Steenson B, Krusenstjerna A, Castro-Padovani T, Savage C, Jutras B, Saylor T. J Bacteriol
DOI: 10.1128/jb.00606-21
Molecular Dynamics Simulations Indicate Aromaticity as a Key Factor in the Inhibition of IAPP (20-29) Aggregation King K, Bevan D, Brown AM. ACS Chem Neurosci
DOI: 10.1021/acschemneuro.2c00025
Behavioral and postural analyses establish sleep-like states for mosquitoes that can impact host landing and blood feeding Ajayi OM, Marlman JM, Gleitz LA, Smith ES, Piller BD, Krupa JA, Vinauger C, Benoit JB. J Exp Biol DOI: 10.1242/jeb.244032
|
|
COVID-19 Outreach Activities by CeZAP Affiliated Faculty Linsey Marr
COVID-19 Publications by CeZAP Affiliated Faculty
Subsewershed SARS-CoV-2 Wastewater Surveillance and COVID-19 Epidemiology Using Building-Specific Occupancy and Case Data Cohen A, Maile-Moskowitz A, Grubb C, Gonazalez R, Ceci A, Darling A, Hungerford L, Fricker Jr. R, Finkielstein C, Pruden A, Vikesland P. ACS EST Water DOI: 10.1021/acsestwater.2c00059.
|
|
Recent Research Grants Awarded to CeZAP Affiliated Faculty
|
|
- DBSP Immune Responses to Recombinant Rotaviruses Expressing Norovirus Capsid Protein $566,429
Human noroviruses (HuNoV) and rotaviruses (HRV) are the leading cause of acute gastroenteritis worldwide. Currently, there is no HuNoV vaccine available. Rotavirus vaccines have been effective in reducing HRV gastroenteritis in infants and young children. In collaboration with Dr. John Patton from Indiana University we aim to develop an oral HuNoV vaccine using rotavirus vaccine as an expression platform through reverse genetics system of rotavirus. We will evaluate the replication capacity, immunogenicity, and protective efficacy of the recombinant live oral vaccine in gnotobiotic pig model of HuNoV and HRV infection and diarrhea.
- Guatemalan government institute (SENACYT) grant to research mosquito vector species and enzootic arboviral circulation in Department Izabal, Guatemala
|
|
|
Gillian Eastwood was recently in Guatemala collaborating with Centro Universitario de Zacapa in mosquito collections and community understanding of vectors and arboviral diseases.
|
|
CeZAP Affiliated Faculty highlighted in
Link+License+Launch: Faculty Inventor Spotlight
|
|
WEBSTER L. SANTOS
My team develops novel drugs for the treatment of various diseases such as non-alcoholic fatty liver disease, multiple sclerosis, and chronic kidney disease. In particular, we are making drugs to target the mitochondria, sphingosine kinase, and sphingosine-1-phosphate transporters READ MORE>>
|
|
|
KEVIN EDGAR
My major fields of interest are the chemistry of natural polysaccharides, glycoscience, creating methods for selective synthesis of derivatives of the complex and challenging polysaccharides, designing sustainable-based materials for optimal performance, biodegradable materials for low environmental impact, and biomedical applications including delivery of poorly soluble, low bioavailability active molecules, and tissue engineering. READ MORE>>
|
|
|
PAUL CARLIER
My team’s expertise in making molecules in the correct “left-handed” or “right-handed” form enantioselective synthesis is critical in these efforts, since only the correctly handed form will have the desired effects. Drug resistance is an ever-present threat to the effective treatment of malaria and bacterial infections. We focus on the development of agents that will kill strains of malaria parasites and pathogenic bacteria that are resistant to known antibiotics. READ MORE>>
|
|
|
X.J. MENG
My research focuses on delineating the mechanisms of viral replication and pathogenesis and developing vaccines against emerging viruses including hepatitis E virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus, and SARS-CoV-2. Since 1999, I have been awarded over $23 million in research funding as principal investigator and over $30 million as co-principal investigator. I have been awarded more than 22 U.S. patents, and my inventions led to development of commercial licensed vaccines on the global markets. READ MORE>>
|
|
|
To Foster and Promote a Cohesive and Synergistic Environment for Interdisciplinary and Collaborative Research
|
|
|
|
|
|